About CAR T-Cell Therapy
CAR T-Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy) is one of the most advanced forms of immunotherapy for cancer. It involves engineering a patient’s own T-cells to target and destroy cancer cells. At Paras Hospital, Srinagar, we specialize in CAR T-Cell treatment for blood cancers such as lymphoma, leukemia, and multiple myeloma, offering cutting-edge care under expert supervision.
Our oncology team combines FDA-approved CAR T-Cell therapies and clinical trial access to provide new hope for patients with relapsed or refractory cancers.
Dr. Saquib Zaffar Banday / Dr Saqib Ahmad Shah
Associate Director
Paras Health, Srinagar
View ProfileCan't Find what you are looking for?
All major insurance accepted
What is CAR T-Cell Therapy?
CAR T-Cell Therapy is a breakthrough cancer treatment where a patient’s T-cells are collected, modified in a lab to recognize cancer cells, and infused back into the body. These “supercharged” cells then seek and destroy cancer cells more effectively.
Cancers Treated with CAR T-Cell Therapy:
-
Acute lymphoblastic leukemia (ALL)
-
Diffuse large B-cell lymphoma (DLBCL)
-
Mantle cell lymphoma (MCL)
-
Follicular lymphoma
-
Multiple myeloma
-
Ongoing research for solid tumors
CAR T-Cell Therapy Options at Paras Hospital, Srinagar
Our cancer immunotherapy specialists offer advanced CAR T-Cell treatment options, including:
FDA-Approved CAR T-Cell Therapies
-
Kymriah (Tisagenlecleucel) for ALL and DLBCL
-
Yescarta (Axicabtagene ciloleucel) for DLBCL
-
Tecartus (Brexucabtagene autoleucel) for mantle cell lymphoma
-
Breyanzi (Lisocabtagene maraleucel) for lymphoma
-
Abecma (Idecabtagene vicleucel) for multiple myeloma
Personalized CAR T-Cell Treatment
Custom-modified T-cells tailored to the patient’s cancer type and genetic profile.
Clinical Trial Access
Opportunities for patients to receive the latest CAR T-Cell therapies under research protocols.
Comprehensive Cancer Care
Supportive treatments including infection control, blood transfusions, and long-term monitoring.
Who Should Consider CAR T-Cell Therapy?
You may be a good candidate if you:
-
Have relapsed or refractory blood cancer (leukemia, lymphoma, multiple myeloma)
-
Did not respond to chemotherapy, radiation, or stem cell transplant
-
Need advanced immunotherapy options for long-term remission
-
Are eligible for CAR T-Cell therapy based on blood tests and overall health evaluation
What to Expect During Treatment
Our CAR T-Cell procedure involves:
-
Consultation & Evaluation: Cancer type, stage, and health assessment.
-
Cell Collection (Leukapheresis): T-cells are extracted from the patient’s blood.
-
Cell Engineering: T-cells are modified in a lab with CAR receptors.
-
Infusion: Modified CAR T-Cells are given back through IV.
-
Recovery & Monitoring: Close observation for side effects like cytokine release syndrome (CRS) or neurotoxicity.
-
Hospital stay is typically 2–3 weeks.
-
Long-term follow-ups ensure cancer remission and safety.
Why Choose Paras Hospital for CAR T-Cell Therapy in Srinagar?
-
Expert Oncologists & Immunotherapy Specialists with advanced global training.
-
State-of-the-Art Cancer Center equipped for complex cellular therapies.
-
Access to FDA-Approved CAR T-Cell Therapies and clinical trials.
-
Personalized Treatment Plans tailored to cancer type and patient health.
-
Comprehensive Multidisciplinary Care including hematology, oncology, and critical care.
-
Trusted by Patients for ethical, innovative, and result-driven cancer treatment.
Book Appointment for CAR T-Cell Therapy in Srinagar
Don’t let relapsed or resistant cancer limit your options. At Paras Hospital, Srinagar, our oncology and immunotherapy team provides advanced CAR T-Cell therapy, offering new hope for patients with blood cancers.
If you’re searching for the best hospital for CAR T-Cell therapy, cancer immunotherapy specialists, or advanced cancer treatment in Srinagar, visit Paras Hospital today.